Patents by Inventor Shuang QI

Shuang QI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10793543
    Abstract: The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, a solvate, an ester, an acid, a metabolite or a prodrug thereof. The compound itself in the present invention or in combination with at least one therapeutic agent can be used for preventing or treating diseases, disorders or symptoms caused by the adjustment of the activity of tyrosine kinase C-KIT, or affected by the activity of the tyrosine kinase C-KIT or involving in the activity of the tyrosine kinase C-KIT, especially cancers or other cell proliferation diseases.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: October 6, 2020
    Assignees: PRECEDO PHARMACEUTICALS CO., LTD, HEFEI GRACEVO BIO-MEDICINE CO., LTD
    Inventors: Qingsong Liu, Jing Liu, Qiang Wang, Beilei Wang, Feiyang Liu, Shuang Qi, Ziping Qi, Fengming Zou, Cheng Chen, Wenchao Wang, Chen Hu, Xiaochuan Liu, Wei Wang, Aoli Wang, Li Wang, Zhenquan Hu, Tao Ren
  • Patent number: 10678594
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for optimizing resource allocation are provided. One of the methods includes: processing a plurality of first objective functions in parallel to determine a plurality of allocation plans, wherein each of the allocation plans corresponds to allocating zero or more of a plurality of resources associated with a platform to a user, and the plurality of first objective functions share one or more dual multipliers; determining a plurality of profits and costs for the platform in parallel based on the plurality of the allocation plans; aggregating the calculated profits and costs using parallel reduction; updating the one or more dual multipliers based on the aggregated costs to determine whether an exit condition is satisfied; if the exit condition is not satisfied, repeating the processing the plurality of the first objective functions based on the updated dual multipliers.
    Type: Grant
    Filed: January 9, 2020
    Date of Patent: June 9, 2020
    Assignee: Alipay Labs (Singapore) Pte. Ltd.
    Inventors: Xingwen Zhang, Feng Qi, Zhigang Hua, Shuang Yang
  • Patent number: 10669238
    Abstract: The present invention provides an inhibitor of Bruton's tyrosine kinase, which is a compound of formula (I), or its pharmaceutically acceptable salt, solvate, ester, acid, metabolite or prodrug. The present invention also provides a pharmaceutical composition comprising the compound. The present invention also provides a method for inhibiting the activity of tyrosine kinase activity or for treating a disease, disorder, or condition, which would benefit from the inhibition of Bruton's tyrosine kinase(s), by using the Bruton's tyrosine kinase inhibitor, as well application of the Bruton's tyrosine kinase inhibitor for the same.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: June 2, 2020
    Assignee: HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES
    Inventors: Jing Liu, Qingsong Liu, Qianmao Liang, Yongfei Chen, Cheng Chen, Aoli Wang, Hong Wu, Kailin Yu, Wei Wang, Chen Hu, Wenchao Wang, Shuang Qi, Beilei Wang, Li Wang
  • Publication number: 20200142743
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for optimizing resource allocation are provided. One of the methods includes: processing a plurality of first objective functions in parallel to determine a plurality of allocation plans, wherein each of the allocation plans corresponds to allocating zero or more of a plurality of resources associated with a platform to a user, and the plurality of first objective functions share one or more dual multipliers; determining a plurality of profits and costs for the platform in parallel based on the plurality of the allocation plans; aggregating the calculated profits and costs using parallel reduction; updating the one or more dual multipliers based on the aggregated costs to determine whether an exit condition is satisfied; if the exit condition is not satisfied, repeating the processing the plurality of the first objective functions based on the updated dual multipliers.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 7, 2020
    Inventors: Xingwen ZHANG, Feng QI, Zhigang HUA, Shuang YANG
  • Publication number: 20200107103
    Abstract: A wireless earphone comprising an in-ear portion which is in contact with a human ear when the wireless earphone is worn. The in-ear portion comprises a wearing surface which couples the human ear canal when the wireless earphone is worn. The in-ear portion is provided with a wearing detection sensor, a sound venting hole and a contact group which are all disposed on the wearing surface. The wearing detection sensor, the sound venting hole and the contact group are all disposed on the wearing surface of the in-ear portion coupling the human ear canal, so that the wearing detection sensor can directly contact the skin of the human body when the earphone is worn, and thus the wearing detection sensor is improved.
    Type: Application
    Filed: May 20, 2019
    Publication date: April 2, 2020
    Inventors: Shuang CHEN, Yuge ZHU, Tianrong DAI, Hongmei WANG, Lin QI
  • Publication number: 20200033650
    Abstract: A sealing structure, a manufacturing method of the sealing structure and a display device including the sealing structure are provided. The display device includes a first substrate and a second substrate which are opposite to each other, and the display device includes an organic layer, an inorganic layer and a sealant adhesive which are on a side of the first substrate facing the second substrate and are sequentially arranged; the organic layer includes an organic-layer overlap portion, an orthographic projection of the organic-layer overlap portion on the first substrate overlaps an orthographic projection of the sealant adhesive on the first substrate, and the organic-layer overlap portion includes a portion outside a region where the inorganic layer is located.
    Type: Application
    Filed: May 28, 2019
    Publication date: January 30, 2020
    Inventors: Shicheng SUN, Xin ZHAO, Chenkai QI, Xianlong FU, Zhiqiang WANG, Shuang HU, Jianfei TIAN
  • Publication number: 20190084960
    Abstract: The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, a solvate, an ester, an acid, a metabolite or a prodrug thereof. The compound itself in the present invention or in combination with at least one therapeutic agent can be used for preventing or treating diseases, disorders or symptoms caused by the adjustment of the activity of tyrosine kinase C-KIT, or affected by the activity of the tyrosine kinase C-KIT or involving in the activity of the tyrosine kinase C-KIT, especially cancers or other cell proliferation diseases.
    Type: Application
    Filed: March 28, 2017
    Publication date: March 21, 2019
    Applicants: PRECEDO PHARMACEUTICALS CO., LTD, HEFEI GRACEVO BIO-MEDICINE CO., LTD
    Inventors: Qingsong LIU, Jing LIU, Qiang WANG, Beilei WANG, Feiyang LIU, Shuang QI, Ziping QI, Fengming ZOU, Cheng CHEN, Wenchao WANG, Chen HU, Xiaochuan LIU, Wei WANG, Aoli WANG, Li WANG, Zhenquan HU, Tao REN
  • Publication number: 20190040013
    Abstract: The present invention provides an inhibitor of Bruton's tyrosine kinase, which is a compound of formula (I), or its pharmaceutically acceptable salt, solvate, ester, acid, metabolite or prodrug. The present invention also provides a pharmaceutical composition comprising the compound. The present invention also provides a method for inhibiting the activity of tyrosine kinase activity or for treating a disease, disorder, or condition, which would benefit from the inhibition of Bruton's tyrosine kinase(s), by using the Bruton's tyrosine kinase inhibitor, as well application of the Bruton's tyrosine kinase inhibitor for the same.
    Type: Application
    Filed: December 22, 2016
    Publication date: February 7, 2019
    Applicant: HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES
    Inventors: Jing LIU, Qingsong LIU, Qianmao LIANG, Yongfei CHEN, Cheng CHEN, Aoli WANG, Hong WU, Kailin YU, Wei WANG, Chen HU, Wenchao WANG, Shuang QI, Beilei WANG, Li WANG